Skip to main content

Regenerx Biopharmaceuticals Inc

RGRXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0000707511

Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.

Superinvestors holding RGRX, Q3 2023

See all superinvestors

No superinvestor reported holding RGRX in Q3 2023.